Normalizing fibromyalgia as a chronic illness

Daniel J. Clauw, Yvonne D’Arcy, Kevin Gebke, David Semel, Lynne Pauer, Kim Jones

    Research output: Contribution to journalReview article

    5 Citations (Scopus)

    Abstract

    Fibromyalgia (FM) is a complex chronic disease that affects 3–10% of the general adult population and is principally characterized by widespread pain, and is often associated with disrupted sleep, fatigue, and comorbidities, among other symptoms. There are many gaps in our knowledge of FM, such that, compared with other chronic illnesses including diabetes, rheumatoid arthritis, and asthma, it is far behind in terms of provider understanding and therapeutic approaches. The experience that healthcare professionals (HCPs) historically gained in developing approaches to manage and treat patients with these chronic illnesses may help show how they can address similar problems in patients with FM. In this review, we examine some of the issues around the management and treatment of FM, and discuss how HCPs can implement appropriate strategies for the benefit of patients with FM. These issues include understanding that FM is a legitimate condition, the benefits of prompt diagnosis, use of non-drug and pharmacotherapies, patient and HCP education, watchful waiting, and assessing patients by FM domain so as not to focus exclusively on one symptom to the detriment of others. Developing successful approaches is of particular importance for HCPs in the primary care setting who are in the ideal position to provide long-term care for patients with FM. In this way, FM may be normalized as a chronic illness to the benefit of both patients and HCPs.

    Original languageEnglish (US)
    Pages (from-to)9-18
    Number of pages10
    JournalPostgraduate Medicine
    Volume130
    Issue number1
    DOIs
    StatePublished - Jan 2 2018

    Fingerprint

    Fibromyalgia
    Chronic Disease
    Delivery of Health Care
    Watchful Waiting
    Professional Education
    Long-Term Care
    Fatigue
    Comorbidity
    Rheumatoid Arthritis
    Primary Health Care
    Sleep
    Asthma
    Drug Therapy
    Pain

    Keywords

    • Education
    • fibromyalgia
    • non-drug therapy
    • pharmacotherapy
    • symptom domain

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Clauw, D. J., D’Arcy, Y., Gebke, K., Semel, D., Pauer, L., & Jones, K. (2018). Normalizing fibromyalgia as a chronic illness. Postgraduate Medicine, 130(1), 9-18. https://doi.org/10.1080/00325481.2018.1411743

    Normalizing fibromyalgia as a chronic illness. / Clauw, Daniel J.; D’Arcy, Yvonne; Gebke, Kevin; Semel, David; Pauer, Lynne; Jones, Kim.

    In: Postgraduate Medicine, Vol. 130, No. 1, 02.01.2018, p. 9-18.

    Research output: Contribution to journalReview article

    Clauw, DJ, D’Arcy, Y, Gebke, K, Semel, D, Pauer, L & Jones, K 2018, 'Normalizing fibromyalgia as a chronic illness', Postgraduate Medicine, vol. 130, no. 1, pp. 9-18. https://doi.org/10.1080/00325481.2018.1411743
    Clauw DJ, D’Arcy Y, Gebke K, Semel D, Pauer L, Jones K. Normalizing fibromyalgia as a chronic illness. Postgraduate Medicine. 2018 Jan 2;130(1):9-18. https://doi.org/10.1080/00325481.2018.1411743
    Clauw, Daniel J. ; D’Arcy, Yvonne ; Gebke, Kevin ; Semel, David ; Pauer, Lynne ; Jones, Kim. / Normalizing fibromyalgia as a chronic illness. In: Postgraduate Medicine. 2018 ; Vol. 130, No. 1. pp. 9-18.
    @article{bcc3aaf5b68c4b43aab8523c5481381a,
    title = "Normalizing fibromyalgia as a chronic illness",
    abstract = "Fibromyalgia (FM) is a complex chronic disease that affects 3–10{\%} of the general adult population and is principally characterized by widespread pain, and is often associated with disrupted sleep, fatigue, and comorbidities, among other symptoms. There are many gaps in our knowledge of FM, such that, compared with other chronic illnesses including diabetes, rheumatoid arthritis, and asthma, it is far behind in terms of provider understanding and therapeutic approaches. The experience that healthcare professionals (HCPs) historically gained in developing approaches to manage and treat patients with these chronic illnesses may help show how they can address similar problems in patients with FM. In this review, we examine some of the issues around the management and treatment of FM, and discuss how HCPs can implement appropriate strategies for the benefit of patients with FM. These issues include understanding that FM is a legitimate condition, the benefits of prompt diagnosis, use of non-drug and pharmacotherapies, patient and HCP education, watchful waiting, and assessing patients by FM domain so as not to focus exclusively on one symptom to the detriment of others. Developing successful approaches is of particular importance for HCPs in the primary care setting who are in the ideal position to provide long-term care for patients with FM. In this way, FM may be normalized as a chronic illness to the benefit of both patients and HCPs.",
    keywords = "Education, fibromyalgia, non-drug therapy, pharmacotherapy, symptom domain",
    author = "Clauw, {Daniel J.} and Yvonne D’Arcy and Kevin Gebke and David Semel and Lynne Pauer and Kim Jones",
    year = "2018",
    month = "1",
    day = "2",
    doi = "10.1080/00325481.2018.1411743",
    language = "English (US)",
    volume = "130",
    pages = "9--18",
    journal = "Postgraduate Medicine",
    issn = "0032-5481",
    publisher = "Medquest Communications LLC",
    number = "1",

    }

    TY - JOUR

    T1 - Normalizing fibromyalgia as a chronic illness

    AU - Clauw, Daniel J.

    AU - D’Arcy, Yvonne

    AU - Gebke, Kevin

    AU - Semel, David

    AU - Pauer, Lynne

    AU - Jones, Kim

    PY - 2018/1/2

    Y1 - 2018/1/2

    N2 - Fibromyalgia (FM) is a complex chronic disease that affects 3–10% of the general adult population and is principally characterized by widespread pain, and is often associated with disrupted sleep, fatigue, and comorbidities, among other symptoms. There are many gaps in our knowledge of FM, such that, compared with other chronic illnesses including diabetes, rheumatoid arthritis, and asthma, it is far behind in terms of provider understanding and therapeutic approaches. The experience that healthcare professionals (HCPs) historically gained in developing approaches to manage and treat patients with these chronic illnesses may help show how they can address similar problems in patients with FM. In this review, we examine some of the issues around the management and treatment of FM, and discuss how HCPs can implement appropriate strategies for the benefit of patients with FM. These issues include understanding that FM is a legitimate condition, the benefits of prompt diagnosis, use of non-drug and pharmacotherapies, patient and HCP education, watchful waiting, and assessing patients by FM domain so as not to focus exclusively on one symptom to the detriment of others. Developing successful approaches is of particular importance for HCPs in the primary care setting who are in the ideal position to provide long-term care for patients with FM. In this way, FM may be normalized as a chronic illness to the benefit of both patients and HCPs.

    AB - Fibromyalgia (FM) is a complex chronic disease that affects 3–10% of the general adult population and is principally characterized by widespread pain, and is often associated with disrupted sleep, fatigue, and comorbidities, among other symptoms. There are many gaps in our knowledge of FM, such that, compared with other chronic illnesses including diabetes, rheumatoid arthritis, and asthma, it is far behind in terms of provider understanding and therapeutic approaches. The experience that healthcare professionals (HCPs) historically gained in developing approaches to manage and treat patients with these chronic illnesses may help show how they can address similar problems in patients with FM. In this review, we examine some of the issues around the management and treatment of FM, and discuss how HCPs can implement appropriate strategies for the benefit of patients with FM. These issues include understanding that FM is a legitimate condition, the benefits of prompt diagnosis, use of non-drug and pharmacotherapies, patient and HCP education, watchful waiting, and assessing patients by FM domain so as not to focus exclusively on one symptom to the detriment of others. Developing successful approaches is of particular importance for HCPs in the primary care setting who are in the ideal position to provide long-term care for patients with FM. In this way, FM may be normalized as a chronic illness to the benefit of both patients and HCPs.

    KW - Education

    KW - fibromyalgia

    KW - non-drug therapy

    KW - pharmacotherapy

    KW - symptom domain

    UR - http://www.scopus.com/inward/record.url?scp=85038410132&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85038410132&partnerID=8YFLogxK

    U2 - 10.1080/00325481.2018.1411743

    DO - 10.1080/00325481.2018.1411743

    M3 - Review article

    VL - 130

    SP - 9

    EP - 18

    JO - Postgraduate Medicine

    JF - Postgraduate Medicine

    SN - 0032-5481

    IS - 1

    ER -